Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study
Shobhit Bhansali(Post Graduate Institute of Medical Education and Research), Anil Bhansali(Post Graduate Institute of Medical Education and Research), Anand Srinivasan(The University of Texas at San Antonio), Mukesh Yadav(Central University of Punjab), Vivekanand Jha(The George Institute for Global Health), Meredith Hawkins(Albert Einstein College of Medicine), Pinaki Dutta(Post Graduate Institute of Medical Education and Research), Shipra Bhansali(Post Graduate Institute of Medical Education and Research), Naresh Sachdeva(Post Graduate Institute of Medical Education and Research), Sunder Mudaliar(University of California, San Diego), Ashish Jain(Manipal University Jaipur), Niranjan Khandelwal(Post Graduate Institute of Medical Education and Research), Ratti Ram Sharma(Post Graduate Institute of Medical Education and Research), Neelam Marwaha(Post Graduate Institute of Medical Education and Research), Vinod Kumar(Government of Himachal Pradesh)
Cited by 123
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2010|1k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Nephrology Dialysis Transplantation|2019|587